| Common Stock, Shares, Issued |
1,150,000 |
shares |
|
Q3 2024 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2024 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$22,573,000 |
USD |
-34% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,385,000 |
USD |
542% |
Q2 2025 |
Q2 2025 |
| Operating Lease, Liability |
$279,000 |
USD |
240% |
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$295,000 |
USD |
251% |
Q2 2025 |
Q2 2025 |
| Property, Plant and Equipment, Gross |
$10,028,000 |
USD |
-47% |
Q2 2025 |
Q2 2025 |
| Operating Lease, Liability, Current |
$103,000 |
USD |
39% |
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$184,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$111,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$16,000 |
USD |
700% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$3,385,000 |
USD |
542% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
Q2 2025 |